Eiger BioPharmaceuticals, Inc.
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA

Last updated:

Abstract:

Methods of treating a hepatitis delta virus (HDV) infection in a human subject are provided. In some embodiments, the method comprises subcutaneously administering to the subject a therapeutically effective amount of pegylated interferon lambda-1a for at least 48 weeks.

Status:
Application
Type:

Utility

Filling date:

23 Aug 2019

Issue date:

24 Jun 2021